Singletto Selected for DARPA’s Embedded Entrepreneur Initiative
Company’s Oxafence® Active Protection platform recognized for transition potential to military and healthcare applications
Singletto Featured as Lead Story in GeekWire
ProGear + Oxafence Masks Receive FDA Clearance and Launch in U.S. Healthcare
Singletto Supported Teledyne FLIR in the U.S. Defense Advanced Research Projects Agency (DARPA) PPB Program
Grand Challenges Annual Meeting to Include MB Presentation
Singletto to Partner with Kenyan Healthcare Organizations on TB Research
Singletto Launches ProGear+Oxafence Masks in New Zealand
aPDI Method Proven Effective Against Norovirus, Coronaviruses, and Ebola, Lassa, and Nipah Viruses, according to WHO and Global Researchers, Including Singletto Co-Founders
Canadian Healthcare Facilities Magazine: Dyes, Light, and Oxygen by Singletto CEO John Bjornson
Singletto Launches Oxafence Mask Spray in New Zealand
Protective Dye Methylene Blue Plus Light Proven to Inactivate "Hard-to-kill" Norovirus
It all begins with an idea.
Infection Control & Hospital Epidemiology Publishes Drs. Lendvay, Chen, et al. WHO-led DeMaND Study
Top Doctor 2021: Singletto’s Lendvay Named by Seattle Magazine
It all begins with an idea.
A Moral Obligation: Why the Former Providence President Wants Singletto Tech Out Now
Hospital News: Light kills. SARS-CoV-2, That Is.
CBC: This Simple Mix of Dye and Light could Decontaminate Masks for Reuse
World Health Organization Updates COVID-19 PPE Guidelines to Include New Decontamination Method: Methylene Blue + Light
From Ebola to SARS-CoV-2: Dr. Mores Recaps His Recent DRC Trip
Light-Activated Dyes Explained by a Foremost Expert
